Advertisement
TAKE Solutions Limited

TAKE Solutions Limited Fundamental Analysis

TAKE.NSNSE
HealthcareBiotechnology
27.75
1.30(4.48%)
Indian Market opens in 47h 47m
Advertisement

TAKE Solutions Limited Fundamental Analysis

TAKE Solutions Limited (TAKE.NS) shows moderate financial fundamentals with a PE ratio of 37.71, profit margin of 20.02%, and ROE of 44.42%. The company generates $0.5B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

ROE44.42%
PEG Ratio-0.53
Current Ratio4.54

Areas of Concern

Operating Margin-4.15%
Cash Position4.47%
We analyze TAKE.NS's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 80.9/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.

Fundamental Health Score

B+
80.9/100

We analyze TAKE.NS's fundamental strength across five key dimensions:

Efficiency Score

Excellent

TAKE.NS demonstrates superior asset utilization.

ROA > 10%
29.94%

Valuation Score

Moderate

TAKE.NS shows balanced valuation metrics.

PE < 25
37.71
PEG Ratio < 2
-0.53

Growth Score

Moderate

TAKE.NS shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Excellent

TAKE.NS maintains a strong and stable balance sheet.

Debt/Equity < 1
0.00
Current Ratio > 1
4.54

Profitability Score

Moderate

TAKE.NS maintains healthy but balanced margins.

ROE > 15%
44.42%
Net Margin ≥ 15%
20.02%
Positive Free Cash Flow
No

Key Financial Metrics

Is TAKE.NS Expensive or Cheap?

P/E Ratio

TAKE.NS trades at 37.71 times earnings. This suggests a premium valuation.

37.71

PEG Ratio

When adjusting for growth, TAKE.NS's PEG of -0.53 indicates potential undervaluation.

-0.53

Price to Book

The market values TAKE Solutions Limited at 13.46 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

13.46

EV/EBITDA

Enterprise value stands at -171.25 times EBITDA. This is generally considered low.

-171.25

How Well Does TAKE.NS Make Money?

Net Profit Margin

For every $100 in sales, TAKE Solutions Limited keeps $20.02 as profit after all expenses.

20.02%

Operating Margin

Core operations generate -4.15 in profit for every $100 in revenue, before interest and taxes.

-4.15%

ROE

Management delivers $44.42 in profit for every $100 of shareholder equity.

44.42%

ROA

TAKE Solutions Limited generates $29.94 in profit for every $100 in assets, demonstrating efficient asset deployment.

29.94%

Following the Money - Real Cash Generation

Operating Cash Flow

TAKE Solutions Limited generates limited operating cash flow of $-30.53M, signaling weaker underlying cash strength.

$-30.53M

Free Cash Flow

TAKE Solutions Limited generates weak or negative free cash flow of $-30.53M, restricting financial flexibility.

$-30.53M

FCF Per Share

Each share generates $-0.21 in free cash annually.

$-0.21

FCF Yield

TAKE.NS converts -0.77% of its market value into free cash.

-0.77%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

37.71

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.53

vs 25 benchmark

P/B Ratio

Price to book value ratio

13.46

vs 25 benchmark

P/S Ratio

Price to sales ratio

7.49

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.00

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.54

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.44

vs 25 benchmark

ROA

Return on assets percentage

0.30

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How TAKE.NS Stacks Against Its Sector Peers

MetricTAKE.NS ValueSector AveragePerformance
P/E Ratio37.7129.63 Worse (Expensive)
ROE44.42%223.00% Weak
Net Margin20.02%-38669.00% (disorted) Strong
Debt/Equity0.000.82 Strong (Low Leverage)
Current Ratio4.544.30 Strong Liquidity
ROA29.94%-379.00% (disorted) Strong

TAKE.NS outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews TAKE Solutions Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ